INDUCTION WITH ALL-TRANS RETINOIC ACID IN COMBINATION WITH IDARUBICIN AND INTENSIVE CONSOLIDATION FOLLOWED BY BONE MARROW TRANSPLANTATION OR A RANDOMIZED MAINTENANCE TREATMENT DEPENDING UPON THE AMOUNT OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan; Cyclophosphamide; Cytarabine; Etoposide; Idarubicin; Mercaptopurine; Methotrexate; Mitoxantrone; Tioguanine; Tretinoin
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 20 Sep 2013 Biomarkers information updated
- 16 Sep 2005 New trial record.